## Self-Evaluation — Assigned issue batch — 2026-09-20
### What I set out to do
Fix the open Oxagen issues assigned to macanderson in parallel.
### What I actually did (measurable deltas)
Inventoried 39 issues and delegated independent kernel, evidence, and skills batches. Fixed the remaining brand-kit selection and surface allowlist defects in #3074. The kit integrity check matched every vendored asset at kit 2.3.0. The missing-kit check reported that no assets were verified.
### Quality of my decisions
- Best decision: read current code and issue decisions before changing older reports. Several fixes had already landed.
- Weakest decision: requested complete issue bodies in one terminal response, which truncated the evidence. Cached individual records instead.
### What I could have done better
- Store the inventory first and print only the fields needed for scheduling.
- Separate production verification requirements from source defects during the first inventory pass.
### What surprised me about this codebase/product
Some reopened issues track unchecked evidence even after their fixes reached main.
### Risks I am leaving behind
The larger batch still includes feature implementation and production verification work. This reflection records the brand change only, not completion of all 39 issues.
### Confidence in the result: high
An independent test-engineer audit found no blocking test gaps. The actual brand kit and missing-kit integrity checks passed. CI owns execution of the new unit tests.
